This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Icks A, Rathmann W, Haastert B, Gandjour A, Holle R, John J, Giani G, KORA Study Group.Clinical and cost-effectiveness of primary prevention of type 2 diabetes in a real world routine healthcare setting: model based on the KORA Survey 2000. Diabetic Medicine 24: 473-480, No. 5, May 2007
Rights and permissions
About this article
Cite this article
Pricey programmes for primary prevention of diabetes. Pharmacoecon. Outcomes News 531, 5 (2007). https://doi.org/10.2165/00151234-200705310-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705310-00010